Here, the systemic metabolic increase of the MTA:SAM ratio suppresses the catalytic activity of PRMT5 activity, which alters tumor cells more than normal cells to mimic the synthetic lethal phenotype (9). The gene discussed is PRMT5; the disease is neoplasm.